Overview
Inger Nijhof practices in Nieuwegein, Netherlands. Ms. Nijhof is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Her top areas of expertise are Multiple Myeloma, Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), and Xanthoma.
Her clinical research consists of co-authoring 52 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Chronic B-Cell Leukemia (CBCL).
Locations
Nieuwegein, UT, Netherlands
Almere Stad, FL, Netherlands
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Graft Versus Host Disease (cGvHD)Ms. Nijhof isDistinguished. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Multiple MyelomaMs. Nijhof isDistinguished. Learn about Multiple Myeloma.
- Experienced
- B-Cell LymphomaMs. Nijhof isExperienced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Ms. Nijhof isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Nijhof isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- COVID-19Ms. Nijhof isExperienced. Learn about COVID-19.
- Graft Versus Host Disease (GvHD)Ms. Nijhof isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Relapsed Refractory Multiple Myeloma (RRMM)